找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn

[复制链接]
查看: 10591|回复: 64
发表于 2025-3-21 16:49:18 | 显示全部楼层 |阅读模式
书目名称Renal Cancer
副标题Current Status and I
编辑Christopher Anderson,Mehran Afshar
视频video
概述Provides a carefully structured insight into the latest developments in renal cancer diagnostics and treatment.Contains clear guidance on the use of hybrid, real and virtual simulation techniques.Feat
图书封面Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn
描述.Renal Cancer: Current Status and Innovations .provides a useful guide to the fundamental basics and latest diagnostic and treatment techniques for Renal Cancer. It features clearly structured and easy-to-understand chapters enabling the reader to develop a thorough understanding of screening, surveillance, diagnostics, pathology, robotic and open surgical approaches, ablation, medical treatment, psychology, and future innovations... The book provides a valuable resource for the full spectrum of clinicians involved in the multidisciplinary management of Renal Cancer..
出版日期Book 2022
关键词Endoscopic Surgery; Cognitive Simulation; Focal Therapies; Laparoscopic Surgery; Percutaneous Treatment;
版次1
doihttps://doi.org/10.1007/978-3-030-84756-2
isbn_softcover978-3-030-84758-6
isbn_ebook978-3-030-84756-2
copyrightSpringer Nature Switzerland AG 2022
The information of publication is updating

书目名称Renal Cancer影响因子(影响力)




书目名称Renal Cancer影响因子(影响力)学科排名




书目名称Renal Cancer网络公开度




书目名称Renal Cancer网络公开度学科排名




书目名称Renal Cancer被引频次




书目名称Renal Cancer被引频次学科排名




书目名称Renal Cancer年度引用




书目名称Renal Cancer年度引用学科排名




书目名称Renal Cancer读者反馈




书目名称Renal Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:16:51 | 显示全部楼层
发表于 2025-3-22 03:15:42 | 显示全部楼层
发表于 2025-3-22 07:39:05 | 显示全部楼层
发表于 2025-3-22 12:14:26 | 显示全部楼层
978-3-030-84758-6Springer Nature Switzerland AG 2022
发表于 2025-3-22 14:16:02 | 显示全部楼层
Metastatic Tumours: Cytoreductive Nephrectomy,tatic renal cell carcinoma. The evidence surrounding this controversial treatment is reviewed and other indications for nephrectomy are discussed. We discuss the complex issues surrounding patient selection and how this may be improved in the future to choose the appropriate case for CRN.
发表于 2025-3-22 18:00:43 | 显示全部楼层
发表于 2025-3-22 22:24:46 | 显示全部楼层
发表于 2025-3-23 05:25:28 | 显示全部楼层
发表于 2025-3-23 05:47:31 | 显示全部楼层
Scott T. C. Shepherd,Samra Turajlicxis and time on the horizontal axis. For Group ., the survival rate (or 1 − the mortality rate) declines steadily over the 5 years of observation. For Group ., however, the decline in the survival rate is rapid during the first year and then levels off. Obviously, the survival experience of the two
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-17 08:28
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表